Последние исследования

EudraCT Number: 2019-000176-41

Sponsor Protocol Number: 341-201-00004

Start Date:

Sponsor Name: Otsuka Pharmaceutical Development & Commercialization, Inc.

Full Title: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Trial to Assess the Efficacy and Safety of Orally Administered OPS-2071 for 12 Weeks in Subjects With Crohn’s ...

Medical condition: Crohn's Disease

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	10017947 - Gastrointestinal disorders	10011401	Crohn's disease	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended) PL (Prematurely Ended) HU (Prematurely Ended) IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2007-004270-43

Sponsor Protocol Number: AIEOP-BFMALL2009

Start Date:

Sponsor Name: Universitätsklinikum Schleswig-Holstein, Campus Kiel

Full Title: International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia

Medical condition: acute lymphoblastic leukemia in children and adolescents 1 to

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.0	100000004864	10000845	Acute lymphoblastic leukemia	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Completed) CZ (Completed) AT (Ongoing) IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-018365-34

Sponsor Protocol Number: RP103-04

Start Date:

Sponsor Name: Raptor Therapeutics Inc.

Full Title: A Long-Term, Open-Label, Safety and Efficacy Study of Cysteamine Bitartrate Delayed-release Capsules (RP103) in Patients with Nephropathic Cystinosis

Medical condition: Cystinosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10011777	Cystinosis	LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Ongoing) NL (Completed)

Trial results: View results

EudraCT Number: 2008-000495-24

Sponsor Protocol Number: V-CT-2

Start Date:

Sponsor Name: ViroLogik GmbH

Full Title: A Multicenter, Open-Label, Pilot Study to Explore the Safety and Efficacy of Intravenous Bortezomib in Patients with Hepatitis C

Medical condition: repeated dose treatment with Bortezomib in patients with chronic HCV infection

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10002724	Anti-HCV positive	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: (No results available)

EudraCT Number: 2009-016442-74

Sponsor Protocol Number: CMM-EM

Start Date:

Sponsor Name: Fundació Clínic per a la Recerca Biomèdica

Full Title: Trasplante autólogo de células madre mesenquimales en esclerosis múltiple: ensayo clínico fase II aleatorizado, enmascarado y cruzado con placebo.

Medical condition: Esclerosis Múltiple

Disease:	Version	SOC Term	Classification Code	Term	Level
	9		10052785	Multiple sclerosis acute and progressive	HLT

Population Age: Adults

Gender: Male, Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-022716-39

Sponsor Protocol Number: DX-88/26

Start Date:

Sponsor Name: Dyax Corp.

Full Title: A 3-Part Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Subcutaneous Ecallantide in Prepubertal Paediatric Patients Experiencing Acute Attacks of Hereditary Angioedema

Medical condition: Hereditary Angioedema

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10019860	Hereditary angioedema	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2021-002308-11

Sponsor Protocol Number: IM047-001

Start Date:

Sponsor Name: Celgene International II Sàrl

Full Title: A phase 2/3, multicenter, randomized, double-blind study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of oral ozanimod (RPC1063) in pediatric subjects with moderately to ...

Medical condition: Moderately to Severely Active Ulcerative Colitis

Disease:	Version	SOC Term	Classification Code	Term	Level
	20.1	10017947 - Gastrointestinal disorders	10045365	Ulcerative colitis	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: PL (Ongoing) DE (Ongoing) ES (Ongoing) BE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2010-020079-22

Sponsor Protocol Number: DG40.08

Start Date:

Sponsor Name: STALLERGENES S.A.

Full Title: Determination of sensitivity and specificity of five solutions of allergen extract (5 grasses, birch, ragweed pollens and Dermatophagoides pteronyssinus and Dermatophagoides farinae mites) for diag...

Medical condition: Allergy to grass pollen Allergy to birch pollen Allergy to ragweed pollen Allergy to mites

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.1		10039085	Rhinitis allergic	LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-003872-37

Sponsor Protocol Number: S63142

Start Date:

Sponsor Name: University Hospitals Leuven

Full Title: 18F-MFBG PET imaging of the norepinephrine transporter in neural crest and neuroendocrine tumors: a phase I PET/CT study

Medical condition: Neural crest tumors and neuroendocrine tumors

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-000114-11

Sponsor Protocol Number: D5290C00004

Start Date:

Sponsor Name: MedImmune, LLC

Full Title: A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, i...

Medical condition: The prevention of medically attended RSV LRTI.

Disease:	Version	SOC Term	Classification Code	Term	Level
	21.1	100000004865	10066742	Respiratory syncytial virus infection prophylaxis	LLT

Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: BE (Completed) LV (Completed) GB (GB - no longer in EU/EEA) SE (Completed) FR (Completed) DE (Completed) CZ (Completed) LT (Completed) EE (Completed) FI (Completed) PL (Completed) AT (Completed) ES (Ongoing) BG (Completed) IT (Ongoing)

Trial results: (No results available)

Последние исследования

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства